Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 3Phase 1 2

Status

Terminated 4Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Genitourinary 1Gastrointestinal 1

Conditions

Glioblastoma 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × TPI-287 × Clear all
NCT02047214 2018-01-31

Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy

Cortice Biosciences, Inc.

Phase 2 Terminated
17 enrolled
CNS

Glioblastoma

NCT01113463 2016-10-31

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

M.D. Anderson Cancer Center

Phase 2 Terminated
17 enrolled 3 charts
CNS

Brain Neoplasms, Glioblastoma

NCT00479635 2014-01-22

A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer

Cortice Biosciences, Inc.

Phase 2 Terminated
26 enrolled
Genitourinary

Prostatic Neoplasms

NCT00553813 2014-01-22

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

Cortice Biosciences, Inc.

Phase 2 Terminated
23 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡